Author

Tarek Dahhan

Observed names: T Dahhan, T. Dahhan

Observed institution: Nederlandse Obesitas Kliniek

OpenAlex ID: A5006550655

1164 Hemoglobine Decline During Peginterferon Alfa-2b/ribavirin Treatment in Real-life Is Associated With Favorable Svr Rates in Difficult-to-treat Patients With Hcv Genotype 1 Infection

2012 · G. Teuber, S. Mauss, et al. · Journal of Hepatology · 1

Behandlung der chronischen Hepatitis C (cHC) mit PegInterferon alfa 2b und Ribavirin bei HIV oder HBV koinfizierten Patienten

2008 · S Mauss, D Hueppe, et al. · Zeitschrift für Gastroenterologie · 1

Treatment and Outcome of Genotype 4 Chronic Hepatitis C Patients With PegInterferon alfa 2b and Ribavirin in the Clinical Setting in Germany

2007 · D. Hueppe, E Zehnter, et al. · 1

Behandlung der chronischen Hepatitis C (cHC) mit Peginterferon alfa–2b und Ribavirin in Deutschland – Ergebnisse der Anwendung unter Alltagsbedingungen als wichtiger Beitrag zur Qualitätssicherung und Versorgungsforschung

2006 · D Hüppe, E Zehnter, et al. · Zeitschrift für Gastroenterologie · 1

High virologic response rate at End of Treatment (EOT) following triple therapy of previously untreated HCV Genotype 1 (G1) infection with boceprevir in German real-life

2014 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie

Treatment of previously untreated patients with chronic HCV genotype 1 infection with Boceprevir (BOC) in German real-life: High efficacy in patients with early virologic response

2014 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie

Considerable efficacy of retreatment of chronic Hepatitis C Genotype 1 (G1) Infection with Boceprevir (Victrelis®) in German Real-Life: Interim results from the ongoing Novus study

2014 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie

Treatment of chronic Hepatitis C Genotype 1 (G1) infection with Boceprevir (BOC) in German Real-Life: Impact of Hemoglobin (Hb) decline on virologic response

2014 · G Teuber, P Buggisch, et al. · Zeitschrift für Gastroenterologie

Su1068 Treatment of Previously Untreated Patients With Chronic HCV Genotype 1 Infection With Boceprevir in German Real-Life: High Efficacy in Patients With Early Virologic Response

2014 · Peter Buggisch, Hanns Löhr, et al. · Gastroenterology

Su1072 Treatment of Chronic Hepatitis C Genotype 1 (G1) Infection With Boceprevir (Victrelis®) in German Real-Life: Impact of Hemoglobin Decline on Virologic Response

2014 · Gerlinde Teuber, Peter Buggisch, et al. · Gastroenterology

P1137 Treatment of Chronic Hcv Genotype 1 (g1) Infection With Boceprevir in German Real-life: High Efficacy Together With Moderate Treatment Discontinuation Rates in Treatment-naive Patients

2014 · P. Buggisch, H. Löhr, et al. · Journal of Hepatology

Treatment of chronic hepatitis C Genotype 1 (G1) infection with boceprevir (Victrelis®) in the German real-life setting: First results for treatment-naïve patients from the Novus observational study

2013 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie

Changes of demographic- and disease characteristics of patients with chronic HCV genotype 1 infection In Germany during the past decade

2013 · P Buggisch, H Löhr, et al. · Zeitschrift für Gastroenterologie

Thyroid dysfunction induced by peginterferon alfa-2b (Peg-2b)/Ribavirin (Rbv) is associated with higher SVR rates in patients with HCV Genotype 1 (G1) infection due to improved early virologic response at week 4 and week 12

2013 · S Mauss, D Hüppe, et al. · Zeitschrift für Gastroenterologie

Leukocytes decline > 2500/µl during Peginterferon Alfa-2B (PEG-2B)/Ribavirin (RBV) treatment predicts favorable SVR rates in difficult-to-treat patients with HCV Genotype 1 (G1) infection in real-life

2013 · G Teuber, S Mauss, et al. · Zeitschrift für Gastroenterologie

Treatment of chronic hepatitis C by Pegylated Interferon Alfa-2b (Peg2b) and Ribavirin (RBV): Age-and gender dependent frequency of hematological alterations in a German real-life cohort

2013 · G Teuber, S Mauss, et al. · Zeitschrift für Gastroenterologie

912 LEUKOCYTE DECLINE PREDICTS SUSTAINED VIROLOGIC RESPONSE IN PATIENTS UNDERGOING PEGINTERFERON alfa-2b/RIBAVIRIN TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION

2013 · G. Teuber, S. Mauss, et al. · Journal of Hepatology

Hemoglobin decline above 2g/dl during Peginterferon alfa-2b (PEG-2B)/Ribavirin (RBV) treatment predicts favorable SVR in patients with HCV genotype 1 and HCV genotype 2/3 infection without erythropoietin use

2013 · G Teuber, S Mauss, et al. · Zeitschrift für Gastroenterologie

Thyroid dysfunction induced by Peginterferon alfa-2B (PEG-2B)/Ribavirin (RBV) is a favorable predictor of SVR in patients with HCV genotype 1 (G1), but not HCV genotype 2/3 (G2/3) infection

2013 · S Mauss, D Hüppe, et al. · Zeitschrift für Gastroenterologie

Age- and gender-related differences in SVR and relapse following treatment of HCV genotype 3 (G3) infection with Peginterferon alfa-2b (peg2b)/Ribavirin (RBV) in real-life

2013 · S Mauss, D Hüppe, et al. · Zeitschrift für Gastroenterologie

Thyroid dysfunction induced by peginterferon alfa-2b (Peg-2b)/Ribavirin (RBV) is a favorable predictor of SVR in difficult-to-treat patients with HCV Genotype 1 (G1) infection

2012 · S Mauss, D Hueppe, et al. · Zeitschrift für Gastroenterologie

Alters- und geschlechtsbedingte Unterschiede bei SVR und Rezidiven nach Therapie der HCV-Genotyp 3-(G3)-Infektion mit Peginterferon Alfa-2b (Peg2b)/Ribavirin (RBV) in der Praxis

2012 · S Mauss, D Hueppe, et al. · Zeitschrift für Gastroenterologie

Age-dependent rise in early Hemoglobin (Hb) decline contributes to a higher frequency of anemia in elder patients treated with peginterferon alfa-2b (Peg2b)/Ribavirin (RBV) for chronic HCV Genotype 1 (G1) infection

2012 · G Teuber, S Mauss, et al. · Zeitschrift für Gastroenterologie

Sa1053 Age-Dependent Rise in Early Hemoglobin (HB) Decline Contributes to a Higher Frequency of Anemia in Elder Patients Treated With Peginterferon Alfa-2B (Peg2b)/Ribavirin (RBV) for Chronic HCV Genotype 1 (G1) Infection

2012 · Gerlinde Teuber, Stefan Mauss, et al. · Gastroenterology

Sa1052 Thyroid Dysfunction Triggered by Peginterferon Alfa-2B / Ribavirin Treatment of Chronic HCV Genotype 1 Infection Favors Sustained Virologic Response (SVR) by Reducing

2012 · Stefan Mauss, Dietrich Hueppe, et al. · Gastroenterology

PDF

Works count: 40

Citation count: 4

H-index: 1

I10-index: